Killifish exhibit distinct structural changes and fibrosis during cardiac aging
Long-lived African turquoise killifish show ventricular enlargement, fibrosis, and reduced myocardial density with age rather than typical cardiomyocyte hypertrophy.
Histology and histopathology · Hishida R et al. · Paper published 28 Sep 2026
In the African turquoise killifish (Nothobranchius furzeri), researchers characterized age-related cardiac remodeling using the long-lived MZCS strain. The authors compared hearts from young fish aged 1.5 months with old fish aged 7 to 10 months of both sexes using histology, quantitative image analysis, and gene expression assays. Old killifish developed ventricular enlargement, epicardial thickening, valvular abnormalities, and prominent interstitial myocardial fibrosis. Unlike findings in mammals and zebrafish, aged killifish did not display cardiomyocyte hypertrophy. Instead, their hearts exhibited reduced myocardial density and marked thinning of peripheral trabeculae. Glycogen-like material accumulation tended to be more pronounced in young fish, while most glucose metabolism genes showed no marked age-related shifts. Furthermore, senescence-associated beta-galactosidase activity was robustly present from early life onward, indicating it is an intrinsic cardiac feature rather than a simple chronological aging marker in this model.
Why it matters
These findings highlight both conserved traits like fibrosis and species-specific mechanisms in vertebrate heart aging. The work establishes the MZCS killifish strain as a viable model for dissecting structural modes of cardiac decline within a short timeframe.
Caveats
The study was conducted in a fish model whose cardiac aging features, such as the lack of cardiomyocyte hypertrophy, diverge from mammalian biology. The analysis was also limited to histological, imaging, and selective marker comparisons between two specific age groups.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Structural and metabolic signatures of cardiac aging in African turquoise killifish (Nothobranchius furzeri)
Hishida R, Otsuka T, Toyokuni S et al.
Histology and histopathology · 28 Sep 2026 · Peer-reviewed
- Relevance
- Core geroscience
- News value
- Notable
- Evidence
- Model organisms
- Status
- Peer-reviewed
More on Cellular senescence
See allDasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
The senolytic combination improved liver fibrosis without disease worsening in nearly half of treated participants while lowering cellular senescence markers.
Nature metabolism · Koning M et al.
A distinct p21-driven macrophage senotype accumulates during aging and liver disease
Researchers identified a p53-p21-Cyclin D2 axis that governs senescent macrophages in mice and human liver cirrhosis and can be cleared with senolytics.
bioRxiv · Torres G et al.
DNA methylation proxies of senescence markers track human disease and mortality
The new blood-based tools estimate senescence gene activity to predict incident diseases, all-cause mortality, and clinical treatment responses.
medRxiv · Simpson DJ et al.
Bispecific T cell engager eliminates senescent cells in mice and nonhuman primates
Monitored by serum transaminase levels, low doses of the drug alleviated age-related pathologies without causing the hepatotoxicity seen at higher doses.
Aging cell · Deng J et al.
A deep learning score for cellular senescence predicts human mortality and disease risk
The proteomic biomarker tracked chronic illness risk in the UK Biobank and shifted following an 18-month multimodal exercise intervention.
Aging cell · Zhao S et al.